CellsBin Wins NCI Award to Advance Myeloma Blood Test
Danbury, Connecticut, USA, October 27, 2026 CellsBin, a biotechnology company developing rare-cell analysis technologies, has received a Direct-to-Phase II...
National Cancer Institute
Advertisement
IMUNON and NCI Advance IMNN-001 Clinical Development
LAWRENCEVILLE, N.J. — September 10, 2026 IMUNON, Inc. announced a Cooperative Research and Development Agreement (CRADA) with the National...
Olio Labs AI Platform Predicts Human Drug Trial Outcomes
South San Francisco, California, August 6, 2026 Olio Labs has presented a new AI-driven in vivo drug discovery platform...
CSHL and Northwell Build 150+ Next-Gen Cancer Models
Cold Spring Harbor, New York, August 5, 2026 Cold Spring Harbor Laboratory (CSHL) and Northwell Health have helped lead...
FibroBiologics Secures European Patent for Cartilage Gene Therapy
Houston, Texas, August 5, 2026 FibroBiologics, Inc. has strengthened its global intellectual property portfolio after the European Patent Office...
Advertisements
NIH Expands Human Cancer Models for Precision Oncology
Bethesda, Maryland, August 5, 2026 The National Institutes of Health (NIH), through the National Cancer Institute (NCI) and its...
Senhwa Biosciences Secures NT$500M GEM Investment Deal
TAIPEI, Taiwan & SAN DIEGO, Calif., July 14, 2026 Senhwa Biosciences, Inc. has entered into a significant financing agreement...
Advertisement
